Home LiteratureArticle Details
PMID: 18985005 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination.

Experimental & molecular medicine ·Vol. 40 ·No. 5 ·2008-10-31 ·Pages 479-85

Jung JE, Kim HS, Lee CS, Shin YJ, Kim YN, Kang GH, Kim TY, Juhnn YS, Kim SJ, Park JW, Ye SK, Chung MH

Abstract

Hypoxia-inducible factor 1alpha (HIF-1alpha) is rapidly degraded by the ubiquitin-proteasome pathway under normoxic conditions. Ubiquitination of HIF-1alpha is mediated by interaction with von Hippel-Lindau tumor suppressor protein (pVHL). In our previous report, we found that hypoxia-induced active signal transducer and activator of transcription3 (STAT3) accelerated the accumulation of HIF-1alpha protein and prolonged its half-life in solid tumor cells. However, its specific mechanisms are not fully understood. Thus, we examined the role of STAT3 in the mechanism of pVHL-mediated HIF-1alpha stability. We found that STAT3 interacts with C-terminal domain of HIF-1alpha and stabilizes HIF-1alpha by inhibition of pVHL binding to HIF-1alpha. The binding between HIF-1alpha and pVHL, negative regulator of HIF-1alpha stability, was interfered dose-dependently by overexpressed constitutive active STAT3. Moreover, we found that the enhanced HIF-1alpha protein levels by active STAT3 are due to decrease of poly-ubiquitination of HIF-1alpha protein via inhibition of interaction between pVHL and HIF-1alpha. Taken together, our results suggest that STAT3 decreases the pVHL-mediated ubiquitination of HIF-1alpha through competition with pVHL for binding to HIF-1 alpha, and then stabilizes HIF-1alpha protein levels.

MeSH Terms
Animals COS Cells Cell Line, Tumor Chlorocebus aethiops Humans Hypoxia-Inducible Factor 1, alpha Subunit/genetics,metabolism Immunoblotting Immunoprecipitation Protein Binding STAT3 Transcription Factor/genetics,metabolism Signal Transduction/genetics,physiology Transfection Ubiquitination Von Hippel-Lindau Tumor Suppressor Protein/genetics,metabolism
Chemicals
Hypoxia-Inducible Factor 1, alpha Subunit STAT3 Transcription Factor Von Hippel-Lindau Tumor Suppressor Protein
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Jung Joo Eun
Department of Pharmacology, Seoul National University College of Medicine, Seoul 110-799, Korea.
Kim Hong Sook
Lee Chang Seok
Shin Yong Jae
Kim Yong Nyun
Kang Gyeong Hoon
Kim Tae You
Juhnn Yong Sung
Kim Sung Joon
Park Jong Wan
Ye Sang Kyu
Chung Myung Hee
References (21)
21 references, click to expand
  1. HIF hydroxylation and the mammalian oxygen-sensing pathway.
    J Clin Invest. 2003 Mar;111(6):779-83 PMID: 12639980
  2. Nur77 upregulates HIF-alpha by inhibiting pVHL-mediated degradation.
    Exp Mol Med. 2008 Feb 29;40(1):71-83 PMID: 18305400
  3. STAT signaling in head and neck cancer.
    Oncogene. 2000 May 15;19(21):2489-95 PMID: 10851047
  4. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.
    Nat Cell Biol. 2000 Jul;2(7):423-7 PMID: 10878807
  5. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
    Gynecol Oncol. 2000 Oct;79(1):67-73 PMID: 11006034
  6. STAT proteins and transcriptional responses to extracellular signals.
    Trends Biochem Sci. 2000 Oct;25(10):496-502 PMID: 11050435
  7. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
    Oncogene. 2000 Nov 16;19(48):5419-27 PMID: 11114718
  8. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.
    J Natl Cancer Inst. 2001 Feb 21;93(4):266-76 PMID: 11181773
  9. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.
    Science. 2001 Apr 20;292(5516):464-8 PMID: 11292862
  10. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus.
    Cell. 2001 Oct 5;107(1):1-3 PMID: 11595178
  11. A conserved family of prolyl-4-hydroxylases that modify HIF.
    Science. 2001 Nov 9;294(5545):1337-40 PMID: 11598268
  12. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Oncogene. 2002 Mar 27;21(13):2000-8 PMID: 11960372
  13. Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2).
    Oncogene. 2002 Mar 27;21(13):2058-65 PMID: 11960378
  14. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression.
    FASEB J. 2002 Aug;16(10):1151-62 PMID: 12153983
  15. Oxygen sensing and molecular adaptation to hypoxia.
    Physiol Rev. 1996 Jul;76(3):839-85 PMID: 8757790
  16. STATs and gene regulation.
    Science. 1997 Sep 12;277(5332):1630-5 PMID: 9287210
  17. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway.
    J Biol Chem. 1999 Mar 5;274(10):6519-25 PMID: 10037745
  18. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells.
    FASEB J. 2005 Aug;19(10):1296-8 PMID: 15919761
  19. Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells.
    Exp Mol Med. 2005 Aug 31;37(4):353-64 PMID: 16155412
  20. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling.
    EMBO Rep. 2006 Jan;7(1):41-5 PMID: 16391536
  21. STATs in oncogenesis.
    Oncogene. 2000 May 15;19(21):2474-88 PMID: 10851046
Article Info
Journal
Experimental & molecular medicine
Abbr.
Exp Mol Med
ISSN
1226-3613
Published
2008-10-31
Pages
479-85
Language
English
Region
United States
NLM ID
9607880
PMCID
PMC2679355
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com